Optimal healing and DAPT duration in today’s complex PCI: the Synergy stent
Chairperson: Ian T. MEREDITH
Objectives:
To learn how the Synergy stent is being used in complex patient subsetsTo learn how durable and bioabsorbable polymers and stent design impact both early and late healing
To understand the current evidence when assessing ischaemic, bleeding and thrombotic risks for specific patient subsets
Lectures
Session objectives
I. Meredith
PCI in elderly patients: device and pharmacotherapy considerations in next generation DES
T. Cuisset
Early healing with Synergy in real-world patients
J.M. De La Torre Hernandez
Optimal revascularisation in multivessel disease and coronary CTO: the Belfast experience
S. Walsh
Synergy in an all-comer population: the SWEET registry
S. Cook
Session evaluation and key learnings
K.G. OldroydShare
More from Boston Scientific
The Lotus valve: advancing treatment options for patients with challenging anatomies
Chairperson: Ted Feldman
Left atrial appendage closure: which patients benefit most?
Chairperson: Maurice BUCHBINDER, Alec VAHANIAN